CollPlant Biotechnologies (OPHI) vs Regentis Biomaterials (RGNT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
CollPlant Biotechnologies is the larger company by market cap ($9.6 million vs $5.0 million), about 1.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OPHI | RGNT |
|---|---|---|
| Share price | $3.13 | $0.7186 |
| Market cap | $9.63M | $5.05M |
| 1-day change | -2.49% | -14.42% |
| YTD return | — | -89.34% |
| EPS (TTM) | $-9.33 | $-2.46 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.37M | — |
| Revenue growth (YoY) | +360.39% | — |
| Net income (latest FY) | $-11.49M | $-13.65M |
| Gross margin | 64.78% | — |
| Operating margin | -484.31% | — |
| Net margin | -484.56% | — |
| 52-week high | $22.50 | $15.50 |
| 52-week low | $2.64 | $0.712 |
| Distance from 52-week high | -86.09% | -95.36% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +1291.59% |
| Average volume | 385.37K | 49.60K |
| Shares outstanding | 3.08M | 7.02M |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Regentis Biomaterials
RGNT stock →Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee.
Health Care · Industrial Specialties
OPHI vs RGNT FAQ
Which is bigger, CollPlant Biotechnologies or Regentis Biomaterials?
CollPlant Biotechnologies (OPHI) is larger, with a market capitalization of $9.63M compared with $5.05M for Regentis Biomaterials (RGNT).
Are CollPlant Biotechnologies and Regentis Biomaterials in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.